Pyoderma gangrenosum: case report
Article Sidebar
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Downloads
Societal impact
Main Article Content
Abstract
Pyoderma gangrenosum is a chronic inflammatory disease, uncommon, with an incidence of 3 to 10 cases per million inhabitants, whose etiology remains unknown but has been associated with multiple systemic conditions in which stands out inflammatory bowel disease. So far, four clinical variants are known to be the most common ulcerative form of all. The diagnosis is mainly clinical and of discard. In histology its characterized by a neutrophilic infiltrate in the dermis. The treatment of choice is oral corticosteroids, although there are many other therapeutic options described. We report a representative case of an ulcerative pyoderma gangrenosum associated with inflammatory bowel disease.
Article Details
References
Wollina U. Pyoderma gangrenosum: a review. Orphanet J Rare Dis. 2007; 2:19.
Spear M. Pyoderma gangrenosum: an overview. Plast Surg Nurs. 2008;28(3):154-7.
Ruocco E, Sangiuliano S, Gravina AG, Miranda A, Nicoletti G. Pyoderma gangrenosum: an up dated review. J Eur Acad Dermatol Venereol. 2009;23(9):1008- 17
Ahmadi S, Powell FC. Pyoderma gangrenosum: uncommon presentations. Clin Dermatol. 2005;23:612- 20
Ruhl AP, Ganz JE, Bickston SJ. Neutrophilic folliculitis and the spectrum of pyoderma gangrenosum in inflammatory bowel disease. Dig Dis Sci. 2007;52(1):18- 24
Hasselmann DO, Bens G, Tilgen W, Reichrath J. Pyoderma gangrenosum: clinical presentation and outcome in 18 cases and review of the literature. J Dtsch Dermatol Ges. 2007;5(7):560-4.
Brooklyn T, Dunnill G, Probert C. Diagnosis and treatment of pyoderma gangrenosum. BMJ. 2006:333(7560):181- 4.
Fonder MA, Cummins DL, Ehst BD, Anhalt GJ, Meyerle JH. Adalimumab therapy for recalcitrant Pyoderma gangrenosum. J Burns Wounds. 2006; 5:66-71
Cummins DL, Anhalt GJ, Monahan T, Meyerle JH. Treatment of pyoderma gangrenosum with intravenous immunoglobulin. Br J Dermatol. 2007;157(6):1235-9.